Ein Business-Meeting (Symbolbild).
Mittwoch, 27.05.2020 18:15 von GlobeNewswire | Aufrufe: 1024

Olainfarm invites to First Quarter 2020 Investor Conference Webinar

Ein Business-Meeting (Symbolbild). © gilaxia / E+ / Getty Images

Olainfarm invites to First Quarter 2020 Investor Conference Webinar

JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on June 3, 2020 at 04:00 PM (EEST). To join the webinar please follow the instructions below.

Webinar will be hosted by the Chairman of Management Board Jeroen Weites and Investor Relations Advisor Jānis Dubrovskis. The presentation will be held in English.

During the webinar JSC Olainfarm representatives will inform about the recent performance of the company and financial results of first quarter of 2020.

After the presentation investors are welcome to ask questions. Due to the limited webinar time please send in your questions until June 2 to e-mail: marta.muizniece@nasdaq.com.

What is a webinar?
Webinar is a virtual conference, during which company’s representative gives information about the company, its activities and future plans. Webinar allows interactive communication and provides an opportunity to ask questions and get answers directly from the company.

How to join the webinar?
All you need is a computer with internet connection and headphones.

To join the webinar, we invite you to register via https://attendee.gotowebinar.com/register/4951321169254776844

You will be provided with the webinar link and instructions to join webinar successfully. When joining the webinar for the first time, you will be asked to download the system application on your computer which will take only few seconds.


ARIVA.DE Börsen-Geflüster

Kurse

-  
0,00%
Olainfarm Chart

Join the webinar and be the first one to hear the news!
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of the company's operations is to produce reliable and effective top -quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 50 countries and territories of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Additional information:  
Jānis Dubrovskis
Investor Relations Advisor of JSC Olainfarm
Phone: +371 29178878
Email: janis.dubrovskis@olainfarm.com

Werbung

Mehr Nachrichten zur Olainfarm Aktie kostenlos abonnieren

E-Mail-Adresse
Benachrichtigungen von ARIVA.DE
(Mit der Bestellung akzeptierst du die Datenschutzhinweise)

Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.


Andere Nutzer interessierten sich auch für folgende News

PR Newswire Thumbnail
02:00 - PR Newswire